Clinical Trial Update: Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product [Phase 2]

View source ↗

Summary

A Phase 2 safety study in scalp psoriasis completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scalp Psoriasis

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Scalp Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-10